Hilton Boston Logan Airport, One Hotel Dr, Boston, Massachusetts, 02128, United States
The HER2 field remains dynamic with the success of Enhertu and Herceptin. In 2023, attention is shifting to non-breast cancer types, where Anti-HER2 therapies are making significant progress. Beyond ADCs, multispecific antibodies, cell therapy, and radiopharmaceuticals are delivering promising outcomes for various cancer types. This comprehensive conference addresses HER2 challenges in breast cancer and non-breast tumors, facilitating the development of diverse therapeutics. The goal is to expand the clinical utility of HER2 as a multi-tumor target, transcending the boundaries of breast cancer.
Digital health and Medtech start-ups are warmly invited to attend Digital Health AI & Data for free. We define start-ups as early-stage UK and international companies less than three years old that are seeking to disrupt the sector through the development of innovative new products or services. A data-driven revolution is gathering pace across healthcare, spanning health providers, life sciences, researchers and start-ups. Allying the explosion of health data, with transformational AI and analytics tools, techniques and capabilities, is reshaping our future healthcare. The dedicated new two-day conference will together health professionals, researchers, analysts, data scientists, start-ups, for educational sessions and best practice case studies the latest and best examples of data science, AI and analytics in action across UK healthcare. The new event dedicated to harnessing the power of data to improve health and care for all.
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our